




Instance: composition-en-66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: CompositionUvEpi
Title: "Composition for vedrop Package Leaflet"
Description:  "Composition for vedrop Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/09/533/001 10ml bottle"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp66b9e568d1a8891a6ff6349ce2c6c5ff)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - vedrop"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Vedrop is and what it is used for </li>
<li>What you need to know before you take Vedrop </li>
<li>How to take Vedrop </li>
<li>Possible side effects </li>
<li>How to store Vedrop </li>
<li>Contents of the pack and other information </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What vedrop is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What vedrop is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Vedrop contains vitamin E (in the form of tocofersolan). It is used to treat lack of vitamin E due to digestive 
malabsorption (where nutrients from the food are not easily absorbed during digestion) in patients from birth 
(full term newborns) up to 18 years of age suffering from chronic cholestasis (a hereditary or congenital 
disease where bile cannot flow from the liver to the intestine). </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take vedrop"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take vedrop"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Vedrop<br />
- If you are allergic to vitamin E (d-alpha-tocopherol) or any of the other ingredients of this medicine (listed 
in section 6). 
- Vedrop must not be used in newborn premature babies. </p>
<p>Warnings and precautions<br />
Talk to your doctor before taking Vedrop if you have: 
* Problems with your kidney or dehydration. Vedrop should be used with caution and your kidney 
function closely monitored, because polyethylene glycol, part of the active substance tocofersolan, may 
damage your kidneys.<br />
* Problems with your liver. Vedrop should be used with caution and liver functions closely monitored. </p>
<p>Other medicines and Vedrop 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.  </p>
<p>Tell your doctor or pharmacist if you are taking:<br />
* Certain medicines to thin the blood (oral anticoagulants such as warfarin). Your doctor will ask you to 
perform blood tests regularly and may adjust their dose to avoid higher risk of bleeding. 
* Fat-soluble vitamins (such as vitamin A, D, E or K) or highly fat-soluble medicines (such as corticoids, 
ciclosporin, tacrolimus, antihistamine). As Vedrop may increase their absorption during digestion, your 
doctor will monitor the treatment effect and adjust the doses if necessary. </p>
<p>Pregnancy and breast-feeding 
No clinical data are available on exposure to this medicine during pregnancy. Inform your doctor if you are 
pregnant as he/she will decide if the medicine may be used.<br />
There is no data on whether or not this medicine is present in the breast milk. Inform your doctor if you 
want to breast-feed. Your doctor will help you decide what is best for you and your child. </p>
<p>Ask your doctor or pharmacist for advice before taking any medicine. </p>
<p>Driving and using machines 
Vedrop is not likely to affect your ability to drive and use machines.  </p>
<p>Vedrop contains sodium methyl parahydroxybenzoate (E219) and sodium ethyl parahydroxybenzoate 
(E215), which may cause allergic reactions (possibly delayed). </p>
<p>Vedrop contains 0.18 mmoles (4.1 mg) sodium per ml. Speak to your doctor if you are on a controlled 
sodium diet. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take vedrop"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take vedrop"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you 
are not sure. </p>
<p>The usual dose is 0.34 ml/kg/day.<br />
Your doctor will prescribe the dose in ml. 
The dose will be adjusted by your doctor according to your vitamin E blood level. </p>
<p>Method of administration 
Swallow the solution with or without water. Use only with the oral syringe provided in the box.<br />
You can take Vedrop before or during your meal, with or without water. </p>
<p>To measure the dose: </p>
<p>1- Open the bottle. 
2- Put the oral syringe included in the pack in 
the bottle. </p>
<p>3-Fill the oral syringe with the liquid by 
pulling the plunger up to the graduation mark 
corresponding to the quantity in millilitres 
(ml) prescribed by your doctor. </p>
<p>4- Remove the oral syringe from the bottle. 
5- Empty the contents of the syringe by 
pushing the plunger to the bottom either:</p>
<ul>
<li>directly into the mouth,<br />
or </li>
<li>into a glass of water and then drink the 
entire content of the glass. </li>
</ul>
<p>6- Close the bottle.<br />
7- Wash the syringe with water. </p>
<p>If you take more Vedrop than you should 
If you take large doses of Vitamin E, you may experience temporary diarrhoea and stomach ache. Talk to 
your doctor or pharmacist if symptoms persist more than two days. </p>
<p>If you forget to take Vedrop 
Skip the missed dose and go back to the regular dosing schedule. Do not take a double dose to make up for a 
forgotten dose. </p>
<p>If you stop taking Vedrop 
Do not stop the treatment without consulting your doctor because lack of vitamin E may come back and 
affect your health. Contact your doctor or pharmacist before stopping. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The following side effects were reported:  </p>
<p>Common side effects (may affect up to 1 in 10 people) </p>
<p>Diarrhoea </p>
<p>Uncommon side effects (may affect up to 1 in 100 people) </p>
<p>Asthenia (feeling of weakness)  </p>
<p>Headache </p>
<p>Loss of hair </p>
<p>Itching </p>
<p>Rash (eruption on the skin) </p>
<p>Abnormal level of sodium in the blood </p>
<p>Abnormal level of potassium in the blood </p>
<p>Increase of transaminases (liver enzymes) </p>
<p>Not known (frequency cannot be estimated from the available data) </p>
<p>Stomach ache </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not 
listed in this leaflet. You can also report side effects directly via the national reporting system listed in 
Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store vedrop"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store vedrop"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the box and the bottle, after EXP. The 
expiry date refers to the last day of that month. </p>
<p>This medicine does not require any special storage conditions.  </p>
<p>Discard the bottle one month after first opening, even if some solution remains.  </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw 
away medicines you no longer use. These measures will help protect the environment. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Vedrop contains 
- The active substance is tocofersolan. Each ml of solution contains 50 mg of d-alpha-tocopherol in the 
form of tocofersolan, corresponding to 74.5 IU of tocopherol. 
- The other ingredients are: potassium sorbate, sodium methyl parahydroxybenzoate (E219) and sodium 
ethyl parahydroxybenzoate (E215) (see end of section 2 for further information on these 2 
ingredients), glycerol, disodium phosphate dodecahydrate, concentrated hydrochloric acid, purified 
water. </p>
<p>What Vedrop looks like and contents of the pack 
Vedrop is a slightly viscous pale yellow oral solution in a brown glass bottle which is closed with a child-
resistant cap. The bottles contain 10 ml, 20 ml or 60 ml of oral solution. Each box contains one bottle and 
one oral syringe (a 1 ml syringe with a 10 ml or 20 ml bottle, a 2 ml syringe with a 60 ml bottle). </p>
<p>Marketing Authorisation Holder 
Recordati Rare Diseases
Immeuble  Le Wilson<br />
70 avenue du General de Gaulle 
92800 Puteaux 
France </p>
<p>Manufacturer 
Recordati Rare Diseases 
Immeuble  Le Wilson<br />
70, avenue du G n ral de Gaulle 
F-92800 Puteaux 
France </p>
<p>or </p>
<p>Recordati Rare Diseases 
Eco River Parc 
30, rue des Peupliers 
F-92000 Nanterre 
France </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder. </p>
<p>Belgique/Belgi /Belgien 
Recordati 
T l/Tel: +32 2 46101 Lietuva 
Recordati AB. 
Tel: + 46 8 545 80  vedija </p>
<p>Recordati Rare Diseases 
Te .: +33 (0)1 47 73 64    </p>
<p>Luxembourg/Luxemburg 
Recordati 
T l/Tel: +32 2 46101 Belgique/Belgien </p>
<p>esk  republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francie </p>
<p>Magyarorsz g 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franciaorsz g  </p>
<p>Danmark 
Recordati AB. 
Tlf : +46 8 545 80 Sverige </p>
<p>Malta 
Recordati Rare Diseases 
Tel: +33 1 47 73 64 Franza </p>
<p>Deutschland 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Nederland 
Recordati 
Tel: +32 2 46101 Belgi  </p>
<p>Eesti 
Recordati AB. 
Tel: + 46 8 545 80 Rootsi </p>
<p>Norge 
Recordati AB. 
Tlf : +46 8 545 80 Sverige  </p>
<p>Recordati Rare Diseases 
 : +33 1 47 73 64   </p>
<p>sterreich 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Deutschland </p>
<p>Espa a 
Recordati Rare Diseases Spain S.L.U. 
Tel: + 34 91 659 28 Polska 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francja  </p>
<p>France 
Recordati Rare Diseases 
T l: +33 (0)1 47 73 64 Portugal 
Jaba Recordati S.A. 
Tel: +351 21 432 95 Hrvatska 
Recordati Rare Diseases 
T l: +33 (0)1 47 73 64 Francuska </p>
<p>Rom nia 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Fran a  </p>
<p>Ireland 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 France </p>
<p>Slovenija 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francija  </p>
<p>sland 
Recordati AB. 
Simi:+46 8 545 80 Sv j  </p>
<p>Slovensk  republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franc zsko  </p>
<p>Italia 
Recordati Rare Diseases Italy Srl 
Tel: +39 02 487 87 Suomi/Finland 
Recordati AB. 
Puh/Tel : +46 8 545 80 Sverige </p>
<p>Recordati Rare Diseases 
  : +33 1 47 73 64   </p>
<p>Sverige 
Recordati AB. 
Tel : +46 8 545 80 Latvija 
Recordati AB. 
Tel: + 46 8 545 80 Zviedrija </p>
<p>United Kingdom 
Recordati Rare Diseases UK Ltd. 
Tel: +44 (0)1491 414This leaflet was last revised in  </p>
<p>This medicine has been authorised under  exceptional circumstances . This means that because of the rarity 
of this disease it has been impossible to get complete information on this medicine.<br />
The European Medicines Agency will review any new information on this medicine every year and this 
leaflet will be updated as necessary. </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p> </div>"""      



Instance: composition-da-66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: CompositionUvEpi
Title: "Composition for vedrop Package Leaflet"
Description:  "Composition for vedrop Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/09/533/001 10ml bottle"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp66b9e568d1a8891a6ff6349ce2c6c5ff)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - vedrop"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLÆGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLÆGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlægsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlægsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "Oversigt over indlægssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlægssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen:  </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal du vide, før du begynder at tage Vedrop </li>
<li>Sådan skal du tage Vedrop </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Vedrop indeholder E-vitamin (i form af tocofersolan). Det bruges til behandling af mangel på E-vitamin, der 
skyldes fordøjelsesrelateret malabsorbtion (når næringsstoffer fra maden ikke optages nemt gennem 
fordøjelsen)  hos patienter fra fødsel (spædbørn født til tiden) op til 18 år, som lider af kronisk kolestase (en 
arvelig eller medfødt sygdom hvor galde ikke kan udskilles fra leveren til tarmene). </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, før du begynder at tage  vedrop"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, før du begynder at tage  vedrop"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Vedrop 
- hvis du er allergisk over for E-vitamin (d-alfa-tocopherol) eller et af de øvrige indholdsstoffer i dette 
lægemiddel (angivet i pkt. 6). 
- Vedrop må ikke gives til præmature spædbørn. </p>
<p>Advarsler og forsigtighedsregler 
Fortæl det til lægen, inden du tager Vedrop, hvis du har: </p>
<ul>
<li>
<p>Problemer med nyrerne eller er dehydreret. Vedrop skal bruges med forsigtighed, og din nyrefunktion 
skal overvåges tæt, da polyethylenglycol, som er en del af det aktive stof tocofersolan, kan medføre 
nyreskader. </p>
</li>
<li>
<p>Problemer med leveren. Vedrop skal bruges med forsigtighed, og leverfunktionen skal monitoreres tæt. </p>
</li>
</ul>
<p>Brug af anden medicin sammen med Vedrop 
Fortæl det altid til lægen eller på apotekspersonalet, hvis du bruger anden medicin, har brugt det for nylig 
eller muligvis vil bruge det.  </p>
<p>Fortæl det til lægen eller på apoteket, hvis du tager:  </p>
<ul>
<li>
<p>Visse blodfortyndende lægemidler (orale antikoagulanter som f.eks. warfarin). Lægen vil regelmæssigt 
ordinere blodprøver og kan justere dosen for at undgå en øget risiko for blødning. </p>
</li>
<li>
<p>Fedtopløselige vitaminer (som f.eks. A-, D-, E- og K-vitamin) eller lægemidler med høj fedtopløselighed 
(som f.eks. kortikoid, ciclosporin, tacrolimus, antihistamin). Da Vedrop øger optagelsen af disse under 
fordøjelsen, vil lægen monitorere behandlingens virkning og om nødvendigt justere dosen. </p>
</li>
</ul>
<p>Graviditet og amning 
Der findes ingen medicinske data om anvendelse af dette lægemiddel under graviditet. Fortæl det til lægen, 
hvis du er gravid, så han/hun kan afgøre om lægemidlet må bruges.<br />
Der findes ingen data om, hvorvidt dette lægemiddel udskilles i modermælken. Fortæl det til lægen, hvis du 
ønsker at amme. Din læge kan hjælpe mig med at beslutte, hvad der er bedst for dig og dit barn. 
Spørg din læge eller apotek til råds, før du tager nogen form for medicin. </p>
<p>Trafik- og arbejdssikkerhed 
Det er usandsynligt, at Vedrop påvirker din evne til at føre motorkøretøj eller betjene maskiner. </p>
<p>Vedrop indeholder natriummethylparahydroxybenzoat (E219) og natriumethylparahydroxybenzoat 
(E215), der kan forårsage allergiske reaktioner (eventuelt forsinket). </p>
<p>Vedrop indeholder 0,18 mmol (4,1 mg) natrium per ml. Tal med in læge, hvis du er på en natriumfattig diæt.  </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sådan skal du tage vedrop"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sådan skal du tage vedrop"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens anvisning. Er du i tvivl, så spørg lægen eller på apoteket. </p>
<p>Den almindelige dosis er 0,34 ml/kg/dag.<br />
Din læge vil ordinere dosen i ml. 
Dosen justeres af lægen i henhold til niveauet af E-vitamin i dit blod. </p>
<p>Indgivelsesmåde 
Opløsningen synkes med eller uden vand. Må kun tages med den orale sprøjte, der er vedlagt i æsken.<br />
Du kan tage Vedrop før og under et måltid og med eller uden vand </p>
<p>Sådan måles dosen: </p>
<p>1- Åbn glasset. 
2- Før den orale sprøjte fra æsken ned i 
glasset. </p>
<p>3-Fyld den orale sprøjte med væske ved at 
trække stemplet tilbage til den streg på 
sprøjten, der svarer til den mængde i milliliter 
(ml), som lægen har ordineret. </p>
<p>4- Tag den orale sprøjte op af glasset.<br />
5-Tøm sprøjtens indhold ved at trykke 
stemplet i bund, enten:</p>
<ul>
<li>direkte ind i munden<br />
eller </li>
<li>ned i et glas vand. Drik herefter hele 
glasset med vand. </li>
</ul>
<p>6- Sæt låg på glasset.<br />
7- Skyl sprøjten med vand. </p>
<p>Hvis du har taget for meget Vedrop 
Hvis du tager store doser E-vitamin, kan du midlertidigt få diaré og mavesmerter.<br />
Tal med din læge eller apotekspersonalet, hvis symptomer vedvarer i mere end to dage. </p>
<p>Hvis du har glemt at tage Vedrop 
Spring den glemte dosis over og tag din næste dosis på almindelig vis. Du må ikke tage en dobbeltdosis som 
erstatning for den glemte dosis. </p>
<p>Hvis du holder op med at tage Vedrop 
Du må ikke stoppe behandlingen uden først at tale med din læge, da mangel på E-vitamin kan vende tilbage 
og påvirke dit helbred. Kontakt din læge eller apotekspersonalet, inden du stopper. </p>
<p>Spørg lægen eller på apoteket, hvis der er noget, du er i tvivl om. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>De følgende bivirkninger blev rapporteret:  </p>
<p>Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 personer) 
 Diaré </p>
<p>Ikke almindelige bivirkninger (kan forekommer hos op til 1 ud af 100 personer) 
 Asteni (føler dig svag)<br />
 Hovedpine 
 Hårtab 
 Kløe 
 Udslæt på huden 
 Unormalt natriumniveau i blodet 
 Unormalt kaliumniveau i blodet 
 Forhøjet niveau af transaminaser (leverenzymer) </p>
<p>Ikke kendt (hyppigheden kan ikke estimeres ud fra forhåndenværende data) 
 Mavesmerter </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Sundhedsstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information om 
sikkerheden af dette lægemiddel. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p> 
Opbevar lægemidlet utilgængeligt for børn. 
 
Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er den sidste 
dag i den nævnte måned. 
 
Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. 
 
Kassér glasset én måned efter første åbning, selv hvis der er noget tilbage.  </p>
<p>Spørg på apoteket, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke smide 
medicinrester i afløbet eller skraldespanden.  </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstørrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstørrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Vedrop indeholder 
- Aktivt stof: tocofersolan. Hver ml opløsning indeholder 50 mg d-alfa-tocopherol i form af 
tocofersolan svarerende til 74,5 IE tocopherol.<br />
- Øvrige indholdsstoffer: Kaliumsorbat, natriummethylparahydroxybenzoat (E219) og 
natriumethylparahydroxybenzoat (E215) (se sidste del af pkt. 2 for yderligere oplysninger om disse 2 
indholdsstoffer), glycerol, dinatriumfosfatdodecahydrat, koncentreret saltsyre, renset vand. </p>
<p>Udseende og pakningsstørrelse 
Vedrop er en let tyktflydende, lys gul opløsning i et brunt glas lukket med et låg med børnesikring. Glasset 
indeholder 10 ml, 20 ml eller 60 ml oral opløsning. Hver æske indeholder ét glas og én oral sprøjte (én 1 ml 
sprøjte med ét 10 ml eller 20 ml glas, én 2 ml sprøjte med ét 60 ml glas). </p>
<p>Indehaver af markedsføringstilladelsen<br />
Recordati Rare Diseases 
Immeuble “Le Wilson" 
70, avenue du General de Gaulle 
F-92800 Puteaux 
Frankrig </p>
<p>Fremstiller 
Recordati Rare Diseases 
Immeuble “Le Wilson" 
70, avenue du Général de Gaulle 
F-92800 Puteaux 
Frankrig </p>
<p>eller </p>
<p>Recordati Rare Diseases 
Eco River Parc 
30, rue des Peupliers 
F-92000 Nanterre 
Frankrig </p>
<p>Hvis du vil have yderligere oplysninger om Vedrop, skal du henvende dig til den lokale repræsentant: </p>
<p>Belgique/België/Belgien 
Recordati 
Tél/Tel: +32 2 46101 Lietuva 
Recordati AB. 
Tel: + 46 8 545 80 Švedija </p>
<p>България 
Recordati Rare Diseases 
Teл.: +33 (0)1 47 73 64 Франция  </p>
<p>Luxembourg/Luxemburg 
Recordati 
Tél/Tel: +32 2 46101 Belgique/Belgien </p>
<p>Česká republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francie </p>
<p>Magyarország 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franciaország  </p>
<p>Danmark 
Recordati AB. 
Tlf : +46 8 545 80 Sverige </p>
<p>Malta 
Recordati Rare Diseases 
Tel: +33 1 47 73 64 Franza </p>
<p>Deutschland 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Nederland 
Recordati 
Tel: +32 2 46101 België </p>
<p>Eesti 
Recordati AB. 
Tel: + 46 8 545 80 Rootsi </p>
<p>Norge 
Recordati AB. 
Tlf : +46 8 545 80 Sverige  </p>
<p>Ελλάδα 
Recordati Rare Diseases 
Τηλ: +33 1 47 73 64 Γαλλία </p>
<p>Österreich 
Recordati Rare Diseases Germany GmbH 
Tel: +49 731 140 554 0 
Deutschland </p>
<p>España 
Recordati Rare Diseases Spain S.L.U. 
Tel: + 34 91 659 28 Polska 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francja  </p>
<p>France 
Recordati Rare Diseases 
Tél: +33 (0)1 47 73 64 Portugal 
Jaba Recordati S.A. 
Tel: +351 21 432 95  </p>
<p>Hrvatska 
Recordati Rare Diseases 
Tél: +33 (0)1 47 73 64 Francuska </p>
<p>România 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Franţa  </p>
<p>Ireland 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 France </p>
<p>Slovenija 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francija  </p>
<p>Ísland 
Recordati AB. 
Simi:+46 8 545 80 Svíþjóð </p>
<p>Slovenská republika 
Recordati Rare Diseases 
Tel: +33 (0)1 47 73 64 Francúzsko  </p>
<p>Italia 
Recordati Rare Diseases Italy Srl 
Tel: +39 02 487 87<br />
Suomi/Finland 
Recordati AB. 
Puh/Tel : +46 8 545 80 Sverige </p>
<p>Κύπρος 
Recordati Rare Diseases 
Τηλ : +33 1 47 73 64 Γαλλία </p>
<p>Sverige 
Recordati AB. 
Tel : +46 8 545 80<br />
Latvija 
Recordati AB. 
Tel: + 46 8 545 80 Zviedrija </p>
<p>United Kingdom 
Recordati Rare Diseases UK Ltd. 
Tel: +44 (0)1491 414Denne indlægsseddel blev senest ændret </p>
<p>Vedrop er godkendt under "særlige omstændigheder". 
Det betyder, at det ikke har været muligt at opnå fuldstændig dokumentation for dette lægemiddel fordi det 
drejer sig om en sjælden sygdom. 
Det europæiske Lægemiddelagentur vurderer hvert år ny information vedrørende dette lægemiddel, og denne 
indlægsseddel vil om nødvendigt blive opdateret </p>
<p>Du kan finde yderligere information om Vedrop på Det europæiske Lægemiddelagenturs hjemmeside: 
http://www.ema.europa.eu/.  </p> </div>"""      





                    
Instance: bundlepackageleaflet-en-66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for vedrop Package Leaflet for language en"
Description: "ePI document Bundle for vedrop Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-66b9e568d1a8891a6ff6349ce2c6c5ff"
* entry[0].resource = composition-en-66b9e568d1a8891a6ff6349ce2c6c5ff

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp66b9e568d1a8891a6ff6349ce2c6c5ff"
* entry[=].resource = mp66b9e568d1a8891a6ff6349ce2c6c5ff
                            
                    
Instance: bundlepackageleaflet-da-66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for vedrop Package Leaflet for language da"
Description: "ePI document Bundle for vedrop Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-66b9e568d1a8891a6ff6349ce2c6c5ff"
* entry[0].resource = composition-da-66b9e568d1a8891a6ff6349ce2c6c5ff

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp66b9e568d1a8891a6ff6349ce2c6c5ff"
* entry[=].resource = mp66b9e568d1a8891a6ff6349ce2c6c5ff
                            
                    



Instance: mp66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Vedrop 50 mg/ml oral solution"
Description: "Vedrop 50 mg/ml oral solution"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/09/533/001 10ml bottle"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Vedrop 50 mg/ml oral solution"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 66b9e568d1a8891a6ff6349ce2c6c5ffListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "vedrop"

* status = #current
* mode = #working

* title = "List of all ePIs associated with vedrop"

* subject = Reference(mp66b9e568d1a8891a6ff6349ce2c6c5ff)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#vedrop "vedrop"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-66b9e568d1a8891a6ff6349ce2c6c5ff) // vedrop en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-66b9e568d1a8891a6ff6349ce2c6c5ff) // vedrop da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-66b9e568d1a8891a6ff6349ce2c6c5ff
InstanceOf: List
Description: "ePI document List for vedrop Package Leaflets"

* insert 66b9e568d1a8891a6ff6349ce2c6c5ffListRuleset
    